No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Neoplasm / biosynthesis
-
Antibodies, Neoplasm / immunology
-
Antibody Formation / drug effects*
-
Antigens, Neoplasm / administration & dosage
-
Antigens, Neoplasm / genetics
-
Antigens, Neoplasm / immunology
-
Antigens, Neoplasm / pharmacology*
-
Cancer Vaccines / administration & dosage
-
Cancer Vaccines / immunology
-
Cancer Vaccines / pharmacology*
-
Cancer Vaccines / therapeutic use
-
Cytotoxicity, Immunologic / drug effects
-
Drug Screening Assays, Antitumor
-
Emulsions
-
Enzyme-Linked Immunosorbent Assay
-
HSP70 Heat-Shock Proteins / administration & dosage
-
HSP70 Heat-Shock Proteins / genetics
-
HSP70 Heat-Shock Proteins / immunology
-
HSP70 Heat-Shock Proteins / pharmacology*
-
Immunity, Cellular / drug effects*
-
Melanoma, Experimental / immunology
-
Melanoma, Experimental / therapy*
-
Melanoma-Specific Antigens
-
Mice
-
Mice, Inbred C57BL
-
Nanostructures*
-
Neoplasm Proteins / administration & dosage
-
Neoplasm Proteins / genetics
-
Neoplasm Proteins / immunology
-
Neoplasm Proteins / pharmacology*
-
Pharmaceutical Vehicles
-
Recombinant Fusion Proteins / administration & dosage
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / immunology
-
Recombinant Fusion Proteins / pharmacology
-
Specific Pathogen-Free Organisms
-
Vaccination
-
Vaccines, Synthetic / administration & dosage
-
Vaccines, Synthetic / immunology
-
Vaccines, Synthetic / pharmacology
-
Vaccines, Synthetic / therapeutic use
Substances
-
Antibodies, Neoplasm
-
Antigens, Neoplasm
-
Cancer Vaccines
-
Emulsions
-
HSP70 Heat-Shock Proteins
-
MAGEA1 protein, human
-
MAGEA3 protein, human
-
Melanoma-Specific Antigens
-
Neoplasm Proteins
-
Pharmaceutical Vehicles
-
Recombinant Fusion Proteins
-
Vaccines, Synthetic